Piotr J.
- Country
- Sweden
- Department
- Universitetssjukhuset Örebro, Medicinkliniken Njursektionen Södra Grev Rosengatan 701 85 Örebro
Research Overview
- Stroke prophylaxis with Apixaban in Chronic Kidney Disease stage 5 patients with Atrial fibrillation (SACK)
- Phase III Randomized Double‑Blind Placebo‑Controlled Trial of Elecoglipron (AZD5004) on Renal Decline and Mortality in Adults with Chronic Kidney Disease
- Evaluation of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation
Data & Insights
Has run more than one trial at 48 of 456 partner sites.
Specializations
Cardiovascular Medicine
This investigator specializes in the management of atrial fibrillation, with particular focus on stroke prevention strategies in complex patient populations.
- Cardiac Arrhythmias
- Stroke Prevention
- Anticoagulation Therapy
The research encompasses innovative approaches to cardiac care in patients with concurrent conditions.
Nephrology
The investigator focuses on treating patients with chronic kidney disease, particularly those with end-stage renal disease (Stage 5 CKD).
- End-Stage Renal Disease
- Dialysis Management
- Renal Complications
Their work addresses the unique challenges of managing kidney disease patients with cardiovascular comorbidities.
Multidisciplinary Care
This investigator specializes in the intersection of cardiovascular and renal medicine, focusing on complex patient care scenarios.
- Cardio-Renal Syndrome
- Therapeutic Management
- Risk Assessment
Their expertise extends to developing treatment strategies for patients with multiple comorbidities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.